LCD L39116: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound — Noridian
Policy LCD-L39116 · Pain Management
New LCD affects billing for musculoskeletal product injections.
Code intelligence
Policy changes, MAC LCD updates, and CMS guidance matched to code M25.5.
Signal breakdown
5 shown · 5 total in platform
Critical
0%
High
60%
Routine
40%
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Policy LCD-L39116 · Pain Management
New LCD affects billing for musculoskeletal product injections.
Policy LCD-DL35010 · Pain Management
New LCD on trigger point injections may impact billing.
Policy LCD-L35456 · Pain Management
Prepare for billing changes in nerve blockade treatments.
Policy LCD-DL40261 · Pain Management
Proposed LCD may alter Pain Management billing processes.
Policy LCD-L33631 · Outpatient
Wellpoint: Outpatient PT/OT coverage criteria active as of Apr 2026
Audit documentation
The Tripwire Audit Pack exports 12 months of Pain Management policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.